Tirzepatide, a recently approved medication, is creating significant buzz in the scientific community as a possible treatment for both type 2 diabetes and weight loss . This dual-action drug works by activating two separate receptors, GLP-1 and GIP, leading to enhanced glycemic management and notable weight reduction in research studies . While ini